Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manesh R Patel

Showing results (521-530 of 596) with videos related to

Pageof 60
Sort By:
Journal of the American College of Cardiology|October 18, 2015
Quality-of-Life and Economic Outcomes of Assessing Fractional Flow Reserve With Computed Tomography Angiography: PLATFORMMark A Hlatky, Bernard De Bruyne, Gianluca Pontone, et al.
JAMA Network Open|June 22, 2022
Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity RevascularizationConnie N Hess, Michael Szarek, Sonia S Anand, et al.
Circulation|April 9, 2017
Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain)Udo Hoffmann, Maros Ferencik, James E Udelson, et al.
Journal of the American College of Cardiology|October 29, 2021
Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization: Insights From VOYAGER PADConnie N Hess, Manesh R Patel, Rupert M Bauersachs, et al.
Nature Reviews. Cardiology|March 31, 2025
Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolismDavide Capodanno, John H Alexander, M Cecilia Bahit, et al.
European Heart Journal|August 25, 2021
Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trialMori J Krantz, Sebastian E Debus, Judith Hsia, et al.
Stroke|May 17, 2019
Stroke in Patients With Peripheral Artery DiseaseBrad J Kolls, Shelly Sapp, Frank W Rockhold, et al.
JACC. Cardiovascular Imaging|August 31, 2020
Sex Differences in Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve: Lessons From ADVANCETimothy A Fairbairn, Rebecca Dobson, Lyne Hurwitz-Koweek, et al.
Lancet (London, England)|June 17, 2014
Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trialL Kristin Newby, Michael S Marber, Chiara Melloni, et al.
Circulation|October 12, 2021
Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PADConnie N Hess, E Sebastian Debus, Mark R Nehler, et al.
Pageof 60

Showing results (521-530 of 596) with videos related to

Sort By:
Pageof 60
Journal of the American College of Cardiology|October 18, 2015
Quality-of-Life and Economic Outcomes of Assessing Fractional Flow Reserve With Computed Tomography Angiography: PLATFORMMark A Hlatky, Bernard De Bruyne, Gianluca Pontone, et al.
JAMA Network Open|June 22, 2022
Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity RevascularizationConnie N Hess, Michael Szarek, Sonia S Anand, et al.
Circulation|April 9, 2017
Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain)Udo Hoffmann, Maros Ferencik, James E Udelson, et al.
Journal of the American College of Cardiology|October 29, 2021
Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization: Insights From VOYAGER PADConnie N Hess, Manesh R Patel, Rupert M Bauersachs, et al.
Nature Reviews. Cardiology|March 31, 2025
Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolismDavide Capodanno, John H Alexander, M Cecilia Bahit, et al.
European Heart Journal|August 25, 2021
Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trialMori J Krantz, Sebastian E Debus, Judith Hsia, et al.
Stroke|May 17, 2019
Stroke in Patients With Peripheral Artery DiseaseBrad J Kolls, Shelly Sapp, Frank W Rockhold, et al.
JACC. Cardiovascular Imaging|August 31, 2020
Sex Differences in Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve: Lessons From ADVANCETimothy A Fairbairn, Rebecca Dobson, Lyne Hurwitz-Koweek, et al.
Lancet (London, England)|June 17, 2014
Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trialL Kristin Newby, Michael S Marber, Chiara Melloni, et al.
Circulation|October 12, 2021
Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PADConnie N Hess, E Sebastian Debus, Mark R Nehler, et al.
Pageof 60